Latest News - Retina

Wednesday, February 08, 2017 | Medical Studies, Retina

ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration

ProtoKinetix updated its stockholders on the testing of neuronal retinal cells in living tissue at the University of British Columbia (“UBC”) under the guidance of Kevin Gregory-Evans…

Read the full story

Friday, February 03, 2017 | Medical Studies, Retina, AMD

Dexamethasone Implant With Anti-VEGF Explored for Wet AMD

Used in combination with antivascular endothelial growth factor (anti-VEGF) therapy, dexamethasone implants (0.7 mg Ozurdex, Allergan) may help some patients with neovascular age-related macular degen…

Read the full story

Thursday, January 26, 2017 | Product Demos, Retina

For the First Time, Surgical Eye Robot Performs Precision Injection in Patient with Retinal Vein Occlusion

Surgeons at the University Hospitals Leuven in Belgium were the first to operate using a surgical robot on a patient with retinal vein occlusion (RVO). Operated by an eye surgeon, the robot uses a nee…

Read the full story

Monday, December 12, 2016 | Clinical Trials, Retina, Ophthotech

Ophthotech Fails Phase 3 Trials of Fovista in Wet Age-Related Macular Degeneration

Ophthotech announced that the prespecified primary endpoint of mean change in visual acuity at 12 months was not achieved in its two pivotal phase 3 clinical trials investigating the superio…

Read the full story

Thursday, December 01, 2016 | Retina

Google AI Matches Diabetic Retinopathy Screens

Ophthalmologists do not have to worry just yet, but data from a new machine learning study suggest computers will be able to screen for diabetic retinopathy with similar accuracy, and better cost-effe…

Read the full story

Thursday, November 17, 2016 | Retina

Assessing Uveitis: Beyond Vitreous Haze

The presentations of uveitis are as varied as the brands of artificial tears at your local drug store. A case of panuevitis can just as easily present with choroidal thickening and headaches as it can…

Read the full story

Friday, October 14, 2016 | Retina, Novartis

Lucentis Recommended by CHMP for EU Approval in Sixth Indication for the Treatment of Visually Impaired Patients

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Lucentis (ranibizumab) to treat patients with visual impairment due to choroidal ne…

Read the full story

Friday, October 14, 2016 | Retina

Spark Therapeutics Launches Initiative to Improve Access to Genetic Testing for Inherited Retinal Diseases

Spark Therapeutics will provide physicians and eligible patients access to genetic testing and counseling for more than 30 genes linked to certain forms of inherited retinal diseases (IRDs), a group o…

Read the full story

Thursday, October 13, 2016 | Partnerships, Retina, Ocular Therapeutix, Regeneron Pharmaceuticals

Ocular Therapeutix and Regeneron Collaborate to Develop a Sustained-Release Formulation of Aflibercept for Wet AMD and Other Retinal Diseases

In a deal that could be worth more than $300 million, Ocular Therapeutix announced that it has entered into a strategic collaboration, option, and license agreement with Regeneron Pharmaceuticals to c…

Read the full story

Thursday, October 13, 2016 | Clinical Trials, Retina, Allegro Ophthalmics

Allegro Ophthalmics Announces Positive Topline Results From DEL MAR Phase 2B Trial Evaluating Luminate in Patients with Diabetic Macular Edema

Allegro Ophthalmics announced that the DEL MAR phase 2b clinical trial evaluating Luminate (ALG-1001) in 136 patients with diabetic macular edema (DME) met its primary and secondary endpoints, demonst…

Read the full story

Thursday, October 13, 2016 | Retina

Retinal Consultants of Arizona Opens Largest, Most Advanced Clinical, Surgical & Retina Research Institute in Phoenix

Retinal Consultants of Arizona (RCA), one of the nation’s leading Retina & Vitreous clinical research and patient treatment facilities, announced the opening of a 35,000 sqaure-foot clinical…

Read the full story

Tuesday, October 11, 2016 | Conferences, Retina

Retina World Congress Releases Full Meeting Agenda

Retina World Congress, a collaboration of international retina societies, announced the publication of its preliminary full agenda for the inaugural meeting to be held February 23-26, 2017, at the Mar…

Read the full story

Tuesday, October 11, 2016 | Clinical Trials, Retina, Genentech

FDA Grants Priority Review to Genentech’s Lucentis Supplemental Biologics License Application for Myopic Choroidal Neovascularization

Genentech announced that the FDA has accepted a supplemental Biologics License Application (sBLA) and granted priority review for Lucentis (ranibizumab) for the treatment of myopic choroidal neovascul…

Read the full story

Monday, October 03, 2016 | Clinical Trials, Retina, Allegro Ophthalmics

Allegro Ophthalmics Announces Last Patient Enrolled in PACIFIC Phase 2b Clinical Trial of Luminate for Non-Proliferative Diabetic Retinopathy

Allegro Ophthalmics announced completion of enrollment in its PACIFIC phase 2b clinical trial that is evaluating the safety and efficacy of Luminate (ALG-1001) in inducing posterior vitreous detachmen…

Read the full story

Friday, September 30, 2016 | Clinical Trials, Retina, Regeneron Pharmaceuticals

Combination Therapy Shows No Benefit Over Aflibercept Alone in Phase 2 AMD Trial

The phase 2 CAPELLA study evaluating aflibercept (Eylea, Regeneron) coformulated with rinucumab (Regeneron), an anti-platelet-derived growth factor (anti-PDGF) receptor beta antibody, in patients with…

Read the full story
Load More